Chronopharmacology of Anti-Convulsive Therapy

Imagem de Miniatura
Arquivos
art_THOME-SOUZA_Chronopharmacology_of_Anti_Convulsive_Therapy_2013.PDF (276.84 KB)
Citações na Scopus
47
Tipo de produção
article
Data de publicação
2013
DOI
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
SPRINGER
Autores
RAMGOPAL, Sriram
LODDENKEMPER, Tobias
Citação
CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS, v.13, n.4, article ID 339, 15p, 2013
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Approximately one-third of patients with epilepsy continue to have seizures despite antiepileptic therapy. Many seizures occur in diurnal, sleep/wake, circadian, or even monthly patterns. The relationship between biomarkers and state changes is still being investigated, but early results suggest that some of these patterns may be related to endogenous circadian patterns whereas others may be related to wakefulness and sleep or both. Chronotherapy, the application of treatment at times of greatest seizure susceptibility, is a technique that may optimize seizure control in selected patients. It may be used in the form of differential dosing, as preparations designed to deliver sustained or pulsatile drug delivery or in the form of 'zeitgebers' that shift endogenous rhythms. Early trials in epilepsy suggest that chronopharmacology may provide improved seizure control compared with conventional treatment in some patients. The present article reviews chronopharmacology in the treatment of epilepsy as well as future treatment avenues.
Palavras-chave
Epilepsy, Chronotherapy, Chronopharmacology, Chronopharmacokinetics, Differential dosing, Seizures, Seizure patterns, Diurnal patterns, Closed loops, Melatonin, Light therapy, Dim light melatonin onset, DLMO, Circadian pattern, Suprachiasmatic nucleus, Seizure tracking, Seizure diary, Chronopharmacodynamics, Pharmacokinetics, Pharmacodynamics
URI
https://observatorio.fm.usp.br/handle/OPI/2233
Referências
  1. Acelajado MC, 2012, J AM SOC HYPERTENS, V6, P66, DOI 10.1016/j.jash.2011.09.001
  2. Assion HJ, 1989, CHRONOPHARMACOLOGY T, P31
  3. Baraldo M, 2008, EXPERT OPIN DRUG MET, V4, P175, DOI 10.1517/17425255.4.2.175
  4. Barcia JA, 2009, NEUROTHERAPEUTICS, V6, P337, DOI 10.1016/j.nurt.2009.01.015
  5. Baxendale S, 2012, EPILEPSY BEHAV, V24, P359, DOI 10.1016/j.yebeh.2012.04.123
  6. Baxendale S, 2008, EPILEPSY BEHAV, V13, P549, DOI 10.1016/j.yebeh.2008.06.009
  7. Bazil CW, 1997, EPILEPSIA, V38, P56, DOI 10.1111/j.1528-1157.1997.tb01077.x
  8. Brigo F, 2012, COCHRANE DB SYST REV, V6
  9. Bruguerolle B, 1998, CLIN PHARMACOKINET, V35, P83, DOI 10.2165/00003088-199835020-00001
  10. Cicolin A, 2006, EPILEPSIA, V47, P82, DOI 10.1111/j.1528-1167.2006.00376.x
  11. Conroy DA, 2012, CHRONOBIOL INT, V29, P35, DOI 10.3109/07420528.2011.636852
  12. Cortez MA, 1997, PEDIATR NEUROL, V16, P220, DOI 10.1016/S0887-8994(97)00017-9
  13. Crespel A, 1998, EPILEPSIA, V39, P150, DOI 10.1111/j.1528-1157.1998.tb01352.x
  14. DEGEN PH, 1994, BIOPHARM DRUG DISPOS, V15, P519, DOI 10.1002/bdd.2510150609
  15. Lieverse R, 2012, Tijdschr Psychiatr, V54, P527
  16. Dieker R, 2009, EPILEPSY BEHAV, V50, P2019
  17. DIJK DJ, 1994, NEUROSCI LETT, V166, P63, DOI 10.1016/0304-3940(94)90841-9
  18. Dokucu ME, 2005, NEUROPSYCHOPHARMACOL, V30, P2216, DOI 10.1038/sj.npp.1300764
  19. Durazzo TS, 2008, NEUROLOGY, V70, P1265, DOI 10.1212/01.wnl.0000308938.84918.3f
  20. Engel J, 2001, EPILEPSIA, V42, P796, DOI 10.1046/j.1528-1157.2001.10401.x
  21. Etienne-Grimaldi MC, 2008, CLIN PHARMACOL THER, V83, P413, DOI 10.1038/sj.clpt.6100297
  22. Ezeugo U, 2009, EXPERT OPIN PHARMACO, V10, P485, DOI [10.1517/14656560802694739 , 10.1517/14656560802694739]
  23. Olano I., 1998, Journal de Pharmacie Clinique, V17, P153
  24. Falcone T, 2004, CLEVE CLIN J MED S2, V71, pS11
  25. Fountain NB, 1998, J CLIN NEUROPHYSIOL, V15, P69, DOI 10.1097/00004691-199801000-00009
  26. Fuse Yuta, 2012, J Circadian Rhythms, V10, P4, DOI 10.1186/1740-3391-10-4
  27. Placidi F, 2000, NEUROLOGY, V54, pS25
  28. Gowers W, 1885, EPILEPSY OTHER CHRON
  29. Guilhoto LMFF, 2011, EPILEPSY BEHAV, V20, P334, DOI 10.1016/j.yebeh.2010.11.017
  30. Gumz ML, 2010, BBA-GENE REGUL MECH, V1799, P622, DOI 10.1016/j.bbagrm.2010.09.003
  31. Hallam KT, 2005, NEUROPSYCHOPHARMACOL, V30, P1400, DOI 10.1038/sj.npp.1300739
  32. Herman ST, 2001, NEUROLOGY, V56, P1453
  33. Herzog AG, 1997, EPILEPSIA, V38, P1082, DOI 10.1111/j.1528-1157.1997.tb01197.x
  34. Hofstra WA, 2011, EPILEPSY RES, V94, P158, DOI 10.1016/j.eplepsyres.2011.01.015
  35. Hofstra WA, 2008, EPILEPSY BEHAV, V13, P438, DOI 10.1016/j.yebeh.2008.06.002
  36. Hofstra WA, 2009, EPILEPSY BEHAV, V14, P617, DOI 10.1016/j.yebeh.2009.01.020
  37. Hofstra WA, 2012, EPILEPSY BEHAV, V23, P320, DOI 10.1016/j.yebeh.2011.12.008
  38. JAESCHKE H, 1985, BIOCHEM PHARMACOL, V34, P1029, DOI 10.1016/0006-2952(85)90606-9
  39. Johansson AS, 2011, J BIOL RHYTHM, V26, P541, DOI 10.1177/0748730411419775
  40. Kabuto H, 1998, EPILEPSIA, V39, P237, DOI 10.1111/j.1528-1157.1998.tb01367.x
  41. Kahane P, 2004, REV NEUROL-FRANCE, V160, pS179
  42. Kaleyias J, 2011, PEDIATR NEUROL, V45, P109, DOI 10.1016/j.pediatrneurol.2011.03.006
  43. Karafin M, 2010, SEIZURE-EUR J EPILEP, V19, P347, DOI 10.1016/j.seizure.2010.05.005
  44. KENNY AM, 1986, NEUROLOGY, V36, P400
  45. King AB, 2012, ENDOCR PRACT, V18, P382, DOI 10.4158/EP11312.OR
  46. KLOTZ U, 1984, CLIN PHARMACOKINET, V9, P469
  47. Kothare SV, 2011, J CLIN NEUROPHYSIOL, V28, P101, DOI 10.1097/WNP.0b013e3182120d30
  48. LABRECQUE G, 1991, PHARMACOL THERAPEUT, V52, P95, DOI 10.1016/0163-7258(91)90088-4
  49. Larson AM, 2012, EPILEPSIA, V53, P1162, DOI 10.1111/j.1528-1167.2012.03515.x
  50. Le S, 2011, EPILEPSY BEHAV, V22, P705, DOI 10.1016/j.yebeh.2011.08.035
  51. Liu L, 2009, CURR TREAT OPTION N, V11, P242, DOI 10.1007/s11940-009-0028-2
  52. Loddenkemper T, 2011, NEUROLOGY, V76, P145, DOI 10.1212/WNL.0b013e318206ca46
  53. MacDonald BK, 2000, ANN NEUROL, V48, P833, DOI 10.1002/1531-8249(200012)48:6<833::AID-ANA3>3.0.CO;2-U
  54. Singh Rupali, 2012, Recent Pat Drug Deliv Formul, V6, P80
  55. Manfredini R, 2004, J PEDIATR-US, V145, P838, DOI 10.1016/j.jpeds.2004.06.079
  56. Oishi Katsutaka, 2006, J Circadian Rhythms, V4, P13, DOI 10.1186/1740-3391-4-13
  57. MEINARDI H, 1975, EPILEPSIA, V16, P353, DOI 10.1111/j.1528-1157.1975.tb06063.x
  58. MIN HK, 1966, FED PROC, V25, P917
  59. Misra UK, 2010, PROG NEUROBIOL, V91, P108, DOI 10.1016/j.pneurobio.2010.01.008
  60. Molina TA, 2011, CHRONOBIOL INT, V28, P714, DOI 10.3109/07420528.2011.597531
  61. MOLINACARBALLO A, 1994, PSYCHIAT RES, V52, P273, DOI 10.1016/0165-1781(94)90073-6
  62. Molina-Carballo A, 2007, NEUROPEDIATRICS, V38, P122, DOI 10.1055/s-2007-985138
  63. Morrell MJ, 2011, NEUROLOGY, V77, P1295, DOI 10.1212/WNL.0b013e3182302056
  64. NAKANO S, 1984, CLIN PHARMACOL THER, V36, P271
  65. NILES LP, 1987, J NEURAL TRANSM, V70, P117
  66. Nobili L, 2009, EPILEPSIA, V50, P2599, DOI 10.1111/j.1528-1167.2009.02169.x
  67. Oggier DM, 2010, ENVIRON SCI TECHNOL, V44, P7685, DOI 10.1021/es100980r
  68. OHDO S, 1989, CHRONOBIOL INT, V6, P229, DOI 10.3109/07420528909056923
  69. Ohdo S, 2007, DRUG METAB PHARMACOK, V22, P3, DOI 10.2133/dmpk.22.3
  70. OHDO S, 1991, CHRONOBIOL INT, V8, P35, DOI 10.3109/07420529109063917
  71. OHDO S, 1992, J CLIN PHARMACOL, V32, P822
  72. Ohdo S, 1996, JPN J PHARMACOL, V70, P253, DOI 10.1254/jjp.70.253
  73. PANAYIOTOPOULOS CP, 1994, EPILEPSIA, V35, P285, DOI 10.1111/j.1528-1157.1994.tb02432.x
  74. PATEL IH, 1982, EPILEPSIA, V23, P283, DOI 10.1111/j.1528-1157.1982.tb06193.x
  75. Pavlova MK, 2004, EPILEPSY BEHAV, V5, P44, DOI 10.1016/j.yebeh.2003.10.013
  76. Pavlova MK, 2012, NEUROLOGY, V78, P1488, DOI 10.1212/WNL.0b013e3182553c23
  77. PETKER MA, 1993, J CLIN PHARM THER, V18, P213, DOI 10.1111/j.1365-2710.1993.tb00616.x
  78. Poh MZ, 2012, EPILEPSIA, V53, pe93, DOI 10.1111/j.1528-1167.2012.03444.x
  79. Portaluppi F, 2007, ADV DRUG DELIVER REV, V59, P940, DOI 10.1016/j.addr.2006.10.011
  80. Quigg M, 1998, ANN NEUROL, V43, P748, DOI 10.1002/ana.410430609
  81. Quigg M, 2000, ANN NEUROL, V48, P117, DOI 10.1002/1531-8249(200007)48:1<117::AID-ANA19>3.0.CO;2-2
  82. Ramgopal S, 2012, EPILEPSIA, V53, P1170, DOI 10.1111/j.1528-1167.2012.03499.x
  83. Raol YH, 2000, EPILEPSIA, V41, P128, DOI 10.1111/j.1528-1157.2000.tb00131.x
  84. Karwa R, 2001, Drug Metabol Drug Interact, V18, P123
  85. Ben-Cherif Wafa, 2012, J Circadian Rhythms, V10, P3, DOI 10.1186/1740-3391-10-3
  86. Reith DM, 2001, CHRONOBIOL INT, V18, P123, DOI 10.1081/CBI-100001176
  87. Ramgopal S, 2012, SEIZURE-EUR J EPILEP, V21, P535, DOI 10.1016/j.seizure.2012.05.011
  88. Ruiz-Miyares F, 2000, REV NEUROLOGIA, V30, P925
  89. Sanchez-Barcelo EJ, 2011, INT J PEDIAT, V2011
  90. Sato Y, 2004, BRIT J ANAESTH, V92, P859, DOI 10.1093/bja/aeh144
  91. Shah A, 2012, J NEUROL, V260, P549
  92. Shah A, 2012, J NEUROL, V26, P549
  93. Sharkey KM, 2011, SLEEP MED, V12, P685, DOI 10.1016/j.sleep.2011.01.016
  94. Shea SA, 2012, NEW ENGL J MED, V367, P175, DOI 10.1056/NEJMcibr1204644
  95. Shekleton JA, 2010, NEUROLOGY, V74, P1732, DOI 10.1212/WNL.0b013e3181e0438b
  96. SHIRKEY RJ, 1985, EUR J CLIN PHARMACOL, V28, P447, DOI 10.1007/BF00544365
  97. Sinha S, 2006, J NEUROL NEUROSUR PS, V77, P1076, DOI 10.1136/jnnp.2006.088385
  98. Stokkan KA, 2001, SCIENCE, V291, P490, DOI 10.1126/science.291.5503.490
  99. Takiguchi T, 2007, PHARMACOGENET GENOM, V17, P1047, DOI 10.1097/FPC.0b013e3282f12a61
  100. Tekade AR, 2010, DRUG DELIV, V17, P581, DOI 10.3109/10717544.2010.501460
  101. Tsioufis C, 2012, AM J HYPERTENS, V25, P279, DOI 10.1038/ajh.2011.236
  102. TUNON MJ, 1992, ARCH INT PHYSIOL BIO, V100, P83, DOI 10.3109/13813459209035264
  103. Uthman BM, 2000, ARCH MED RES, V31, P300, DOI 10.1016/S0188-4409(00)00060-6
  104. VAGNUCCI AH, 1969, J APPL PHYSIOL, V26, P720
  105. Van Dycke A, 2010, EPILEPSIA, V51, P1721, DOI 10.1111/j.1528-1167.2010.02700.x
  106. Waterhouse J, 2000, CHRONOBIOL INT, V17, P539, DOI 10.1081/CBI-100101063
  107. Yalyn O, 2006, EPILEPSY BEHAV, V8, P542, DOI 10.1016/j.yebeh.2005.12.015
  108. Yegnanarayan R, 2006, CHRONOBIOL INT, V23, P1035, DOI 10.1080/07420520600921112
  109. Yildiz FG, 2012, J NEUROL SCI, V315, P33, DOI 10.1016/j.jns.2011.12.009
  110. YOSHIYAMA Y, 1989, J CLIN PHARMACOL, V29, P1048
  111. Youan BBC, 2004, J CONTROL RELEASE, V98, P337, DOI 10.1016/j.jconrel.2004.05.015
  112. Zarowski M, 2011, EPILEPSIA, V52, P1076, DOI 10.1111/j.1528-1167.2011.03023.x

Coleções
Artigos e Materiais de Revistas Científicas - FM/Outros
Artigos e Materiais de Revistas Científicas - HC/IPq
Artigos e Materiais de Revistas Científicas - LIM/21